Latest news on Modular facilities Manufacturers market Research Report by 2035
Modular Facilities in Pharmaceutical and Biotechnology Market: Industry Trends and Global Forecasts” report features an extensive study of the current landscape, offering an informed opinion on the likely evolution of the market for modular facilities in the healthcare domain, over the next decade.
berry_cristan
The report features an in-depth analysis, highlighting the capabilities of various stakeholders engaged in this domain.
Key Inclusions
§ An executive summary of the key insights captured during our research, offering a high-level view on the current state of the modular facilities market and its likely evolution in the short to mid and long term.
§ A brief introduction to important concepts related to modular facilities, featuring information on different types of modular constructs, as well as primary applications of modular facilities in the pharmaceutical and biotech market. Further, this chapter highlights the recent advancements that have been reported in this market space.
§ A detailed assessment of the current market landscape of modular facilities, highlighting the contributions of various service providers, along with information on their year of establishment, company size (small, mid-sized and large), location of headquarters (North America, Europe, Asia and rest of the world), type of industry served (pharmaceutical, biotechnology), geographical coverage (North America, Europe, Asia and rest of the world), GMP compliance, type of modular construction (relocatable, permanent), type of material used (steel, wood and concrete) and quality certification(s) obtained.
§ A detailed review of the overall landscape of the modular cleanroom providers market, highlighting the contributions of various players, along with information on their year of establishment, company size (small, mid-sized and large) , location of headquarters (North America, Europe, Asia, MENA and rest of the world), type of industry served (pharmaceutical, biotechnology), type of modular cleanroom offered (hardwall, softwall and unspecified), type of cleanroom component offered (air handling units, HEPA filters, ULPA filters, laminar air flow units, air showers, pass throughs, biosafety cabinets, cleanroom furniture, plumbing / piping, lighting / electrical, doors and windows) and quality certification(s) obtained.
§ An in-depth company competitiveness analysis of modular facility service providers, segmented into three categories, namely small (2-50 employees), mid-sized (51-500 employees) and large (>500 employees) players. Within the respective peer groups, companies were ranked based on various relevant parameters, such as service strength (based on the years of experience), company competitiveness (based on parameters, such as type of industry served, GMP compliance, type of modular construction and type of material used), as well as partnership activity (in terms of number of partnerships and type of agreements).
§ Elaborate profiles of prominent players that are currently engaged in offering modular facilities. Each profile features a brief overview of the company (with information on year of establishment, number of employees, location of headquarters and key members of the executive team), details related to their respective service portfolio, recent developments and an informed future outlook.
§ An analysis of the partnerships inked between various stakeholders in this domain, during the period 2012-2022, featuring a detailed set of analyses based on various parameters, such as year of partnership, type of partnership, type of product, type of modular facility, location of modular facility, geographical location of the companies involved and most active players.
§ A detailed case study on modular projects undertaken by modular facility manufacturers in the pharmaceutical and biotechnology industry, along with information on type of modular facility, size of modular facility, number of projects delivered and location of modular facility.
§ An insightful analysis on facility construction trends observed in the pharmaceutical industry over the last seven years, highlighting facility construction projects established by top 20 pharma / biotech players, along with the information on number of facilities, type of facility, purpose of facility, investments made in modular projects, size of facility and location of headquarters.
§ An insightful framework that enables a thorough examination of the cost and time related benefits offered by the use of different modular approaches, by considering multiple parameters, including long-term benefits and sustainability, to identify the most appropriate solution for various types of end users and enabling them to make informed decisions.
§ A review of emerging industry trends, including the combination of single-use technologies / continuous processing technologies with modular facilities, the shift to using smaller, multi-purpose modular facilities, and technological advancements in modular construction processes.
§ A detailed discussion on the various growth drivers, such as development of personalized medicines, biosimilars, orphan drugs and anticipated increase in the adoption of modular solutions in the emerging markets by pharmaceutical / biopharmaceutical CMOs.
The report also features the likely distribution of the current and forecasted opportunity across important market segments, mentioned below:
§ Size of Facility
§ Small Plants
§ Mid-sized Plants
§ Large Plants
§ Very Large Plants
§ Type of Industry Served
§ Pharmaceutical
§ Biotechnology
§ Type of Modular Construct
§ Hybrid Skid Modular Constructs
§ Plug-and-Play Modular Constructs
§ Skid-Mounted Modular Constructs
§ Truckable Modular Constructs
§ Others Modular Constructs
§ Type of Construction Component
§ Process Equipment
§ Base Building
§ Mechanical, Electrical and Plumbing System
§ Process Commodities
§ Other Construction Components
§ Type of Facility
§ Manufacturing
§ Aseptic Filling
§ Research and Development
§ Others
§ Scale of Operation
§ Clinical
§ Commercial
§ Type of Product
§ Cell and Gene Therapies
§ Vaccines
§ Biosimilars
§ Monoclonal Antibodies
§ Advanced Pharmaceuticals
§ Sterile Products
§ Viral Vectors
§ Other Products
§ Type of Expansion
§ New Facilities
§ Facility Expansions
§ Planned Expansions
§ Type of Modular Construction
§ Relocatable
§ Permanent
§ Type of Material
§ Steel
§ Wood
§ Concrete
§ Key Geographical Regions
§ North America
§ Europe
§ Asia
§ Middle East and North Africa (MENA)
§ Rest of the world
Key Questions Answered
§ Who are the key service providers engaged in providing modular facility constructs to pharmaceutical and biotechnology industries?
§ What are the key factors driving the adoption of modular facilities in the pharma / biotech industries?
§ Which are the key regions where modular facilities are being installed by pharma / biotech firms?
§ Which types of products are currently manufactured / processed in modular facilities?
§ Which global regions are currently considered as hubs of modular construction service providers?
§ What are the key strategies that can be implemented by emerging players / start-ups to enter this market?
§ Which partnership models are commonly adopted by stakeholders in the modular facilities domain?
§ How is the current and future opportunity likely to be distributed across key market segments?
To view more details on this report, click on the link
https://www.rootsanalysis.com/reports/view_document/modular-manufacturing-market/178.html
You may also be interested in the following titles:
|
Decentralized Clinical Trials / Virtual Clinical Trials Market |
You may also like to learn what our experts are sharing in Roots educational series:
|
Unlocking the Potential of Digital Twins in Healthcare: Benefits, Challenges and Opportunities |
About Roots Analysis
Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.
Contact:
Ben Johnson
+1 (415) 800 3415
